Clinical trial
Phase 3, Single Center, Controlled, Investigator-blinded, Randomized Matched Pair Design Study of CD4 Cell Recovery in HIV-1 Patients With Sustained Virologic Response Comparing Protease Inhibitor and Non-nucleoside Reverse Transcriptase Inhibitor Based Treatment Regimes
NCT00966160 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3, Single Center, Controlled, Investigator-blinded, Randomized Matched Pair Design Study of CD4 Cell Recovery in HIV-1 Patients With Sustained Virologic Response Comparing Protease Inhibitor and Non-nucleoside Reverse Transcriptase Inhibitor Based Treatment Regimes
- Lead sponsor
- University of Cologne
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 1999
- Completion date
- December 31, 2008
- Enrollment
- 215 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.